Layer 1
News | All clinical

Refine

E.g., 14/10/2019
E.g., 14/10/2019
NHS England blacklisted headlice treatments from prescriptions in March
In March, NHS England published guidance advising GPs to “curb prescribing” for 35 conditions (see the full list here) including headlice – which the...
28/11/2018 9
EXCLUSIVE
Seqirus: It is usual practice to begin taking Fluad orders for the following season in September
Indira Panchal, owner of Meiklejohn Pharmacy in Bedford, told C+D that last week (November 20) she ordered around £1,500-worth of Fluad – currently...
27/11/2018 7
EXCLUSIVE
31% of respondents to C+D's poll submitted a yellow card report in the past year
Almost a third (31%) of 107 community pharmacist respondents to the poll – which C+D ran between August and September 2018 – said they had submitted...
23/11/2018 2
The DH made the decision to restrict gluten-free prescribing in February
The Department of Health and Social Care (DH) decided in February that “bread and [flour] mixes only” should remain available across England,...
22/11/2018 10
QIVc and TIV-HD vaccines are expected to be licensed in December
As well as the adjuvanted trivalent vaccine (aTIV) – which is the only vaccine pharmacies are allowed to administer to this age group this flu season...
21/11/2018 3
Pharmacists will also be able to prescribe antibiotics where necessary under a PGD
The service is available now in selected pharmacies across England, Scotland and Wales to patients aged over 18, the multiple said yesterday (...
20/11/2018 8
EXCLUSIVE
The court dismissed Pfizer’s attempt to prevent generic pregabalin from being used to treat certain types of pain, such as neuropathic pain,...
15/11/2018 0
Pfizer argued its branded pregabalin should be the only version prescribed for pain
The legal battle was last seen in the Court of Appeal in 2016, which upheld the previous year’s High Court decision that Pfizer’s patent for...
15/11/2018 2
PSNC: Pharmacies should be aware prescriptions for cannabis-based medicines may be presented
The rescheduling of cannabis-derived medicinal products from schedule 1 to schedule 2 under the Misuse of Drugs Regulations 2001 was laid before...
01/11/2018 3
An initial nine concessionary prices for October were announced last week. */ Drug Strength Form Price Brimonidine 0.2% eye drops (5) £3.17...
29/10/2018 2

Pages